Cite
Catalase inhibition can modulate the ability of peripheral blood T cells to undergo apoptosis in Crohn's disease.
MLA
Moret-Tatay, Inés, et al. “Catalase Inhibition Can Modulate the Ability of Peripheral Blood T Cells to Undergo Apoptosis in Crohn’s Disease.” Clinical & Experimental Immunology, vol. 217, no. 1, July 2024, pp. 45–56. EBSCOhost, https://doi.org/10.1093/cei/uxad134.
APA
Moret-Tatay, I., Nos, P., Iborra, M., Rausell, F., & Beltrán, B. (2024). Catalase inhibition can modulate the ability of peripheral blood T cells to undergo apoptosis in Crohn’s disease. Clinical & Experimental Immunology, 217(1), 45–56. https://doi.org/10.1093/cei/uxad134
Chicago
Moret-Tatay, Inés, Pilar Nos, Marisa Iborra, Francisco Rausell, and Belén Beltrán. 2024. “Catalase Inhibition Can Modulate the Ability of Peripheral Blood T Cells to Undergo Apoptosis in Crohn’s Disease.” Clinical & Experimental Immunology 217 (1): 45–56. doi:10.1093/cei/uxad134.